Mackie et al., 1991 - Google Patents
The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesisMackie et al., 1991
- Document ID
- 12731977359815800947
- Author
- Mackie A
- Ferrington C
- Cowan S
- PALMER K
- Publication year
- Publication venue
- Alimentary pharmacology & therapeutics
External Links
Snippet
Gastric emptying was measured in 9 diabetic patients with autonomic neuropathy (Group 1) and 8 normal controls (Group 2) on 4 occasions after swallowing placebo, 0.5, 1.0 or 2.0 mg of the newly developed prokinetic drug renzapride given double‐blind and in random order …
- 229950003039 Renzapride 0 title abstract description 34
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nowak et al. | Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. | |
Ricci et al. | Effect of metoclopramide in diabetic gastroparesis | |
McCallum et al. | Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics. | |
Mackie et al. | The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis | |
US5945107A (en) | Compositions and methods for weight reduction | |
CN101903033A (en) | The purposes of the extract of making by Folium Ginkgo | |
DE2823174A1 (en) | MEDICINAL PRODUCTS FOR THE PROPHYLACTIC TREATMENT OF POSTOPERATIVE DEEP VEIN THROMBOSIS | |
Kendall et al. | The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post‐vagotomy–antrectomy gastroparesis | |
Raptis et al. | Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man | |
CN108042755A (en) | It is a kind of to be used to treat weakness of the spleen and the stomach oral traditional Chinese medicine composition and its application | |
Kivistö et al. | Enhancement of absorption and effect of glipizide by magnesium hydroxide | |
CN110664906A (en) | Preparation method of health food with blood sugar reducing function | |
EP0098975B1 (en) | Biostimulating drug | |
KR101888475B1 (en) | Compostions for reducing weight using herb medicine | |
Said et al. | A double blinded-randomized clinical study with “Weighlevel”, a combination of four medicinal plants used in traditional Greco-Arab and Islamic medicine | |
DE60020833T2 (en) | MELATONIN FOR THE TREATMENT OF PARALYSIS LEAVED BY BRAIN HIT | |
Yun et al. | Anti-hypertensive effect of Chunghyul-dan (Qingxue-dan) on stroke patients with essential hypertension | |
CN109999042A (en) | Composition and its application comprising dehydrobenzene or its sulfuric ester, levocarnitine, acetyl levocarnitine or their officinal salt | |
CN109528968A (en) | A kind of Chinese medicine composition and its preparation method and application for treating diabetes B | |
Minocha et al. | Erythromycin shortens orocaecal transit time in diabetic male subjects: a double‐blind placebo‐controlled study | |
Luisto et al. | Dantrolene sodium in chronic spasticity of varying etiology: A DOUBLE‐BLIND STUDY | |
WO2020233459A1 (en) | Composition for improving memory and preparation method therefor | |
Durnin et al. | The metabolic effects, and the composition of the tissue lost, in weight reduction by obese patients on treatment with fenfluramine | |
Stacher et al. | Lack of systematic effects of the 5‐hydroxytryptamine 3 receptor antagonist ICS 205‐930 on gastric emptying and antral motor activity in patients with primary anorexia nervosa. | |
Horowitz et al. | Effect of dexfenfluramine on gastric emptying of a mixed solid-liquid meal in obese subjects |